Cancer vaccines could be available before the end of the decade, say the team behind one of the pandemic’s most successful Covid vaccines. Uğur Şahin and Özlem Türeci, founders of BioNTech, the German company that co-developed an mRNA Covid vaccine with Pfizer, say they have made hopeful breakthroughs in developing cancer vaccines.
ttn-3
“Vaccines to treat cancer may be possible by 2030”"founders of BioNTech . report
